pI: 6.1156 |
Length (AA): 209 |
MW (Da): 24155 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
6 | 94 | 2f6m (B) | 29 | 118 | 28.00 | 0 | 0.79 | 0.87 | -2.08 |
106 | 199 | 2g3k (A) | 148 | 241 | 31.00 | 0 | 0.84 | 0.99 | -2.56 |
6 | 94 | 2f6m (B) | 29 | 118 | 28.00 | 0 | 0.75 | 0.867537 | -1.22 |
102 | 200 | 2j9w (A) | 120 | 220 | 32.00 | 0 | 0.89 | 1.04228 | -1.87 |
106 | 199 | 2j9u (A) | 148 | 241 | 34.00 | 0.0000000091 | 0.79 | 0.984861 | -1.65 |
107 | 163 | 3k4g (A) | 262 | 321 | 42.00 | 0.22 | 0.53 | 0.566827 | 0.6 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128770)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G05000 | vacuolar protein sorting-associated protein 28-2 |
Arabidopsis thaliana | AT4G21560 | vacuolar protein sorting-associated protein 28-1 |
Babesia bovis | BBOV_IV010370 | vacuolar sorting protein 28, putative |
Brugia malayi | Bm1_03915 | VPS28 protein homolog |
Candida albicans | CaO19.212 | transport of soluble vacuolar hydrolase precursors |
Candida albicans | CaO19.7844 | transport of soluble vacuolar hydrolase precursors |
Dictyostelium discoideum | DDB_G0285295 | vacuolar protein sorting 28 family protein |
Drosophila melanogaster | Dmel_CG12770 | Vacuolar protein sorting 28 |
Echinococcus granulosus | EgrG_000630700 | vacuolar protein sorting associated protein 28 |
Echinococcus multilocularis | EmuJ_000630700 | Vacuolar protein sorting associated protein |
Homo sapiens | ENSG00000160948 | vacuolar protein sorting 28 homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.35.5420 | vacuolar protein sorting-associated protein-like protein |
Leishmania donovani | LdBPK_365400.1 | vacuolar protein sorting-associated protein-like protein |
Leishmania infantum | LinJ.36.5400 | vacuolar protein sorting-associated protein-like protein |
Leishmania major | LmjF.36.5170 | vacuolar protein sorting-associated protein-like protein |
Leishmania mexicana | LmxM.36.5170 | vacuolar protein sorting-associated protein-like protein |
Loa Loa (eye worm) | LOAG_05532 | VPS-28 protein |
Mus musculus | ENSMUSG00000059323 | vacuolar protein sorting 28 (yeast) |
Oryza sativa | 4327840 | Os01g0781000 |
Saccharomyces cerevisiae | YPL065W | ESCRT-I subunit protein VPS28 |
Schistosoma japonicum | Sjp_0211830 | Vacuolar protein sorting-associated protein 28 homolog, putative |
Schistosoma mansoni | Smp_067540 | hypothetical protein |
Trypanosoma brucei gambiense | Tbg972.11.12030 | vacuolar sorting-associated protein-like, putative |
Trypanosoma brucei | Tb927.11.10740 | vacuolar sorting-associated protein-like, putative |
Trypanosoma congolense | TcIL3000.11.11400 | vacuolar sorting-associated protein-like, putative |
Trypanosoma cruzi | TcCLB.506155.50 | vacuolar protein sorting-associated protein-like, putative |
Theileria parva | TP01_0691 | hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.2510 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.2510 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.2510 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.01.2510 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.